Citrato De Ytrio (90y) Cis Bio International

Yttrium (90y) Citrate is a radiopharmaceutical used for targeted radiation therapy. It is administered intraarticularly for localized treatment.

Yttrium (90y) Citrate is primarily used in radiation therapy to deliver targeted radiation to specific areas within joints. This radiopharmaceutical is designed for intraarticular use, making it suitable for treatments that require localized radiation delivery. It is often considered for conditions that may benefit from targeted radiation therapy within the joint space.

Yttrium (90y) Citrate works by delivering radiation directly to the targeted area, which can help in reducing abnormal cell growth. The effects are localized, aiming to minimize impact on surrounding healthy tissues. Patients may experience relief from symptoms associated with the targeted condition over time.

Handling Yttrium (90y) Citrate requires strict adherence to safety protocols due to its radioactive nature. It should only be administered by trained healthcare professionals in a controlled environment. Proper shielding and protective measures are essential to ensure safety during handling and administration.

Yttrium (90y) Citrate may interact with other radioactive substances or medications that affect bone metabolism. It is important to disclose all current medications and treatments to the healthcare provider before administration. Alcohol and certain medications may also influence the effectiveness and safety of the treatment.